On March 10, 2019 Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, reported that members of the management team will participate in the following investor conferences in Europe and U.S. in the coming months (Press release, NicOx, MAR 10, 2019, View Source [SID1234534197]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 39th Annual Health Care Conference, March 11-13 in Boston, U.S.
Oppenheimer’s 29th Annual Healthcare Conference, March 19-20 in New York, U.S.
H.C. Wainwright Global Life Sciences Conference, April 7-9 in London, UK
SmallCap Event, April 16-17 in Paris, France
European MidCap Event, May 16 in Copenhagen, Denmark
BIO 2019, June 2-6 in Philadelphia; U.S.
European MidCap Event, June 18-19 in Paris, France
Nicox will present at the Cowen, Oppenheimer and H.C. Wainwright conferences and members of the management team will be available for one-on-one meetings at all these conferences.